U.S., Liberia kick off trial of Ebola drug ZMapp

February 27, 2015 5:55 PM

4 0

U.S., Liberia kick off trial of Ebola drug ZMapp

CHICAGO (Reuters) - U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries.

The trial, a joint effort by the Liberian government and the National Institute of Allergy and Infectious Diseases (NIAID), will be conducted in Liberia and the United States among adults and children infected with Ebola, NIAID said on Friday.

Also read: Ohio State attacker was angry about treatment of Muslims, official says

Read more

To category page

Loading...